Page last updated: 2024-12-07

n-(3-oxohexanoyl)-3-aminodihydro-2(3h)-furanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(3-oxohexanoyl)-3-aminodihydro-2(3H)-furanone: cpd synthesized by luminous bacteria excreted into medium that induces luciferase synthesis at threshold concentration; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-(3-oxohexanoyl)homoserine lactone : A N-acyl homoserine lactone that is the monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 3-oxohexanoic acid with the amino group of homoserine lactone. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID119133
CHEMBL ID16203
CHEBI ID29640
SCHEMBL ID79602
MeSH IDM0096781

Synonyms (47)

Synonym
8-(ethylsulfanyl)-3,7-dihydro-1h-purine-2,6-dione
n-(3-oxo-hexanoyl)-homoserine lactone
LMFA08030003
76924-95-3
n-(3-oxohexanoyl)homoserine lactone
0814EA09-13C0-49CC-AF29-96D6C2FC339F
n-(beta-ketocaproyl)-dl-homoserine lactone
autoinducer 1
3-oxo-n-(tetrahydro-2-oxo-3-furanyl)hexanamide
vai-1
ai-1 (vibrio fischeri)
CHEMBL16203
chebi:29640 ,
AKOS005107755
3-oxo-n-(2-oxotetrahydrofuran-3-yl)hexanamide
3-oxo-n-(2-oxooxolan-3-yl)hexanamide
ai-1 lactone
hexanamide, 3-oxo-n-(tetrahydro-2-oxo-3-furanyl)-
n-(3-oxohexanoyl)-3-aminodihydro-2(3h)-furanone
ohhl-n
n-(beta-ketocaproyl)homoserine lactone
luciferase autoinducer
FT-0670618
n-(3-oxohexanoyl)-homoserine lactone
143537-62-6
n-(ketocaproyl)-l-homoserine lactone
3-oxo-c6-ahl
n-(beta-ketocapryloyl)-homoserine lactone
SCHEMBL79602
MS-2575
YRYOXRMDHALAFL-UHFFFAOYSA-N
n-(3-oxohexanoyl)-dl-homoserine lactone
mfcd03788849
n-(beta-ketocaproyl)-dl-homoserine lactone, analytical standard
J-007830
n-(-ketocaproyl)-dl-homoserine lactone
3-oxo-n-(2-oxotetrahydro-3-furanyl)hexanamide
n-(ketocaproyl)-d,l-homoserine lactone
3-oxo-n-(2-oxooxolan-3-yl)hexanimidic acid
DTXSID20998213
Q27110198
3-oxo-c6-homoserine lactone
Y13555
HY-129405
n-(ketocaproyl)-dl-homoserine lactone
CS-0105302
STARBLD0013715

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Our analysis of dose-response curves of multiple LuxN mutants pins these inverse phenotypes on quantifiable opposing shifts in the free-energy bias of LuxN for occupying its kinase and phosphatase states."( Deducing receptor signaling parameters from in vivo analysis: LuxN/AI-1 quorum sensing in Vibrio harveyi.
Bassler, BL; Swem, DL; Swem, LR; Wingreen, NS, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
N-acyl homoserine lactoneA monocarboxylic acid amide resulting from the formal condensation of a carboxylic acid with the amino group of homoserine lactone. A class of autoinducers generally involved in bacterial quorum sensing.
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID102696Concentration required for half-maximal activation of LuxR protein was determined by following the luminescence of the biosensor strain2002Bioorganic & medicinal chemistry letters, Apr-22, Volume: 12, Issue:8
New synthetic analogues of N-acyl homoserine lactones as agonists or antagonists of transcriptional regulators involved in bacterial quorum sensing.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (127)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (2.36)18.7374
1990's36 (28.35)18.2507
2000's50 (39.37)29.6817
2010's33 (25.98)24.3611
2020's5 (3.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.73 (24.57)
Research Supply Index4.87 (2.92)
Research Growth Index5.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews15 (11.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other114 (88.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]